- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rabbit antithymocyte globulin
Total 1997 results
-
The First Affiliated Hospital of Xiamen UniversityCompletedDiabetes Mellitus, Type 2China
-
Mannkind CorporationCompletedType 1 Diabetes MellitusUnited States, Brazil, Russian Federation, Ukraine
-
Huazhong University of Science and TechnologyCompleted
-
Catholic University of the Sacred HeartCompletedCoronary Artery Disease | Coronary StenosisItaly
-
Amphastar Pharmaceuticals, Inc.Completed
-
Fundación Pública Andaluza para la Investigación...CompletedType 1 Diabetes MellitusSpain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Denmark, Hungary, Slovenia, Switzerland, Bulgaria
-
Diasome PharmaceuticalsIntegriumCompletedDiabetes Mellitus, Type 1United States
-
Hospices Civils de LyonTerminated
-
University of North Carolina, Chapel HillWakeMed Health and HospitalsCompletedPregnancy | Non Insulin Dependent DiabetesUnited States
-
Novo Nordisk A/SCompletedHealthy | DiabetesGermany
-
FDA Office of Orphan Products DevelopmentChildren's Hospital of PhiladelphiaCompleted
-
Becton, Dickinson and CompanyCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSpain
-
SanofiCompletedType 2 Diabetes MellitusChina, Taiwan, Korea, Republic of
-
Novo Nordisk A/SCompleted
-
University of CambridgeMedical University of Graz; University Hospital Inselspital, Berne; Manchester...CompletedType 1 DiabetesUnited Kingdom, Austria, Switzerland
-
Halozyme TherapeuticsCompletedType 1 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Arab Emirates, Malaysia, India, South Africa, Algeria, Lebanon
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1India, Macedonia, The Former Yugoslav Republic of, Malaysia, Turkey, Croatia, Bulgaria, Romania, Australia, South Africa, Argentina
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, France, Denmark, Sweden, Netherlands, Belgium, Finland, Macedonia, The Former Yugoslav Republic of, Norway, Israel, Spain, Croatia, Slovenia, United Kingdom, Switzerland, Ireland
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Sweden
-
AdociaEli Lilly and CompanyCompleted
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingFollicular Lymphoma | Acute Myeloid Leukemia | Multiple Myeloma | Hodgkin Lymphoma | Lymphoplasmacytic Lymphoma | Acute Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Plasma Cell Leukemia | Bone Marrow Failure Syndromes | Burkitt's Lymphoma | Acute Lymphoblastic Leukemia... and other conditionsUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host Disease | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Fundacion para la Investigacion Biomedica del Hospital...University of Alcala; Hospital Universitario Ramon y Cajal; Instituto de Salud... and other collaboratorsRecruitingPolycystic Ovary Syndrome | Hyperandrogenism | Type 1 Diabetes | Hirsutism | Oligomenorrhea | Ovulation DisorderSpain
-
Emory UniversitySanofiCompletedDiabetic KetoacidosisUnited States
-
University Hospital, GrenobleCompleted
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIsrael, Italy, United Kingdom, Denmark, Spain, Singapore, Taiwan, Germany, France, Hong Kong, Brazil
-
Novo Nordisk A/SCompletedHealthy | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNetherlands, United Kingdom
-
SepNet - Critical Care Trials GroupNovo Nordisk A/S; German Federal Ministry of Education and Research; B. Braun... and other collaboratorsCompletedSeptic Shock | Severe SepsisGermany
-
Centre hospitalier de l'Université de Montréal...Radiological Society of North America; Centre de Recherche du Centre Hospitalier... and other collaboratorsCompletedStudy of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes (LIRAINS)Type 2 Diabetes | Nonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisCanada
-
Legacy Health SystemJuvenile Diabetes Research Foundation; Oregon Health and Science UniversityCompletedType 1 DiabetesUnited States
-
Eli Lilly and CompanyCompletedA Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsDiabetes Mellitus, Type 2Romania, Italy, Belgium, Poland, Greece, Germany, United Kingdom, Turkey, Czech Republic, Slovakia
-
Beijing HospitalNot yet recruitingType 2 Diabetes MellitusChina
-
Emory UniversityCompletedBenefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States
-
Nemours Children's ClinicJuvenile Diabetes Research FoundationCompletedDiabetes Mellitus, Type 1United States
-
Sansum Diabetes Research InstituteNovo Nordisk A/SCompletedDiabetes Mellitus, Type 1United States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Tulane University Health Sciences CenterCompleted
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR)Completed
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Russian Federation, Serbia, Turkey, Algeria, Czechia
-
Institut de Recherches Cliniques de MontrealRéseau de recherche en santé cardiométabolique, diabète et obésitéCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Israel, Czechia, Greece, Italy, United States, Bulgaria, Croatia, Denmark, France, Hungary, Romania, Serbia, Slovakia, Sweden, Switzerland, United Kingdom
-
Novo Nordisk A/SCompleted
-
Florida Atlantic UniversityAdvanced Diabetes Treatment CentersTerminatedDiabetes MellitusUnited States
-
AstraZenecaEli Lilly and CompanyCompleted
-
Profil Institut für Stoffwechselforschung GmbHSanofiCompleted
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentCompletedType 2 Diabetic Patients | Insufficient Metabolic Control | OAD TreatmentGermany